Rakuten Medical to Present New Data of Alluminox™ Treatment using ASP-1929 in Combination with anti-PD-1 at AHNS 2023
Medical Device Manufacturing Outsourcing Market size to grow by USD 46,241.15 million from 2022 to 2027; Growing focus of OEMs on reducing medical device manufacturing costs
Global Pharma, Biotech and Diagnostics Distribution Partnering Analysis Report 2023 with a Directory of 2,200 Deals
Syntec Optics, a Leading Optics and Photonics Company, to Publicly List on Nasdaq through Business Combination with OmniLit Acquisition Corp.
TEXAS CHILDREN’S HOSPITAL’S DR. PETER HOTEZ AND DR. MARIA ELENA BOTTAZZI RECEIVE THE 2023 LYNDON B. JOHNSON MORAL COURAGE AWARD
America’s Best Wings: Everything You Need to Know
Toulouse: against noise pollution at the airport, associations and elected officials demonstrate
Bronchiolitis: promising results for preventive treatment
Scientists unveil first human ‘pan-genome’
Tarn-et-Garonne: workshops to stimulate your memory at the Moissac Health Center
Skin and pit of avocado, from waste to cosmetics
SAN DIEGO, May 12, 2023 /PRNewswire/ — Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercializing precision, cell-targeting therapies based on its proprietary Alluminox™...